Cover Image
市場調查報告書

院內感染性肺炎(HAP):全球臨床實驗檢討

Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 321706
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
院內感染性肺炎(HAP):全球臨床實驗檢討 Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月22日 內容資訊: 英文 83 Pages
簡介

本報告提供院內感染性肺炎(HAP)的臨床試驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 院內感染性肺炎(HAP)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5個國家的臨床實驗數量
    • 中南美主要5個國家的臨床實驗數量

G7各國臨床實驗數量:感染疾病臨床實驗上院內感染性肺炎(HAP)所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病臨床實驗上院內感染性肺炎(HAP)所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

院內感染性肺炎(HAP)治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • AstraZeneca PLC
    • Cubist Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Johnson & Johnson
    • Evolva Holding SA
    • Sanofi
    • KaloBios Pharmaceuticals, Inc.
    • Merck & Co., Inc.
    • Janssen Pharmaceuticals, Inc.
    • Basilea Pharmaceutica AG
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Thessaly
    • Prince of Songkla University
    • Universite Victor Segalen Bordeaux 2
    • University of Athens
    • Denver Health and Hospital Authority
    • St. Joseph's Hospital and Medical Center
    • Mahidol University
    • Arak University of Medical Sciences
    • Hospital Pablo Tobon Uribe
    • Hamedan University of Medical Sciences

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2484CTIDB

GlobalData's clinical trial report, "Hospital Acquired Pneumonia (HAP) Global Clinical Trials Review, H2, 2014" provides data on the Hospital Acquired Pneumonia (HAP) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hospital Acquired Pneumonia (HAP). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hospital Acquired Pneumonia (HAP). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hospital Acquired Pneumonia (HAP)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hospital Acquired Pneumonia (HAP)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Evolva Holding SA
      • Clinical Trial Overview of Evolva Holding SA
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • KaloBios Pharmaceuticals, Inc.
      • Clinical Trial Overview of KaloBios Pharmaceuticals, Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Janssen Pharmaceuticals, Inc.
      • Clinical Trial Overview of Janssen Pharmaceuticals, Inc.
      • Basilea Pharmaceutica AG
      • Clinical Trial Overview of Basilea Pharmaceutica AG
    • Clinical Trial Overview of Top Institutes / Government
      • University of Thessaly
      • Clinical Trial Overview of University of Thessaly
      • Prince of Songkla University
      • Clinical Trial Overview of Prince of Songkla University
      • Universite Victor Segalen Bordeaux 2
      • Clinical Trial Overview of Universite Victor Segalen Bordeaux 2
      • University of Athens
      • Clinical Trial Overview of University of Athens
      • Denver Health and Hospital Authority
      • Clinical Trial Overview of Denver Health and Hospital Authority
      • St. Joseph's Hospital and Medical Center
      • Clinical Trial Overview of St. Joseph's Hospital and Medical Center
      • Mahidol University
      • Clinical Trial Overview of Mahidol University
      • Arak University of Medical Sciences
      • Clinical Trial Overview of Arak University of Medical Sciences
      • Hospital Pablo Tobon Uribe
      • Clinical Trial Overview of Hospital Pablo Tobon Uribe
      • Hamedan University of Medical Sciences
      • Clinical Trial Overview of Hamedan University of Medical Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hospital Acquired Pneumonia (HAP) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Evolva Holding SA, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by KaloBios Pharmaceuticals, Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceuticals, Inc., 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Thessaly, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Prince of Songkla University, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite Victor Segalen Bordeaux 2, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Athens, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Denver Health and Hospital Authority, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Hospital and Medical Center, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Pablo Tobon Uribe, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamedan University of Medical Sciences, 2014*

List of Figures

  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hospital Acquired Pneumonia (HAP) to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hospital Acquired Pneumonia (HAP) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hospital Acquired Pneumonia (HAP) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top